|
|
Article: FDA issues draft guidance on committee members' financial interests.(Ethics/conflict of interest)
- Article from:
- Adverse Event Reporting News
- Article date:
- November 5, 2007
- Author:
CopyrightCOPYRIGHT 2007 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FDA has released a draft guidance to help advisory committee members and FDA staff "to understand and implement statutory requirements and FDA policy regarding public availability of information about financial interests and waivers granted by FDA topermit individuals to participate in advisory committee meetings."
The guidance, "Public Availability of Advisory Committee Members' Financial Interest Information and Waivers," describes the basis and provides a format for public disclosure of certain financial interests by special government employees (SGEs) and regular government employees participating in these advisory committee meetings, and provides a format ...